Compare BCRX & SHAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BCRX | SHAZ |
|---|---|---|
| Founded | 1986 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.8B |
| IPO Year | 1995 | 2025 |
| Metric | BCRX | SHAZ |
|---|---|---|
| Price | $9.95 | $55.48 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 3 |
| Target Price | $20.82 | ★ $46.67 |
| AVG Volume (30 Days) | ★ 2.9M | 1.7M |
| Earning Date | 05-06-2026 | 06-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 381.40 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $25,186,000.00 | $1,566,631.00 |
| Revenue This Year | N/A | $8,711.27 |
| Revenue Next Year | $12.55 | $587.87 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 257.44 |
| 52 Week Low | $6.00 | $16.55 |
| 52 Week High | $11.22 | $97.48 |
| Indicator | BCRX | SHAZ |
|---|---|---|
| Relative Strength Index (RSI) | 55.95 | 43.60 |
| Support Level | $8.79 | $47.51 |
| Resistance Level | $10.32 | $77.92 |
| Average True Range (ATR) | 0.32 | 5.46 |
| MACD | 0.02 | -0.79 |
| Stochastic Oscillator | 81.17 | 15.67 |
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
SharonAI Holdings Inc is a neocloud operator, purpose-built to power the next generation of artificial intelligence (AI) and high-performance computing (HPC). The Company's infrastructure is architected from the ground up to meet the specific, intensive, and complex demands of modern AI training and inference workloads, machine learning, and Generative AI. Its services include: Sovereign AI Australia, GPU-as-a-Service, SHARON AI Cloud, SHARON AI Private Cloud, Virtual Private Clusters, HPC Servers, and SHARON AI Studio. The company's products are: SHARON AI Supercluster, GPU Fleet, Virtual Servers, Cloud Storage, and Machine Learning & Infrastructure. The Company operates in one operating segment, High Performance Compute Services (HPC).